An industry source said “most, if not all” of the people at CDRH who were recently dismissed are now being asked to return.
Starting today, people with Parkinson's disease will have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology.
The FDA’s authorisation of Medtronic’s BrainSense follows the system’s receipt of a CE mark in Europe last month.
Do you feel tired or have a headache when you wake up in the morning? Something might be going wrong while you sleep that you ...
The Trump administration is reinstating some employees in the Food and Drug Administration's medical devices division after ...
The reversal is the latest example of President Donald Trump and billionaire Elon Musk's chaotic approach to cost-cutting, ...
HHS secretary Robert F. Kennedy Jr. has been on the receiving end of two heated letters from lawmakers outlining the threats ...